(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics
 
 
Alternative Scenarios - 3
Blood Banking - 105
Cancer - 92
Clinical Chemistry - 262
Coagulation - 89
Decentralized Testing - 3
DNA Probes/Biochips - 33
Genetic Testing - 1
Hematology/Flow Cytometry - 98
Hemostasis - 70
Histology/Cytology - 2
Immunodiagnostics - 26
Infectious Diseases - 295
Microbiology Testing - 80
Molecular Diagnostics - 141
NAT - 82
POC Testing - 163
Strategic Planning - 24
Top 10 Companies - 22
Transfusion Testing - 84
Tumor Markers - 75
 
 In Vitro Diagnostics Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  1  2  3  4  5  6  7  8  9  10  Next »
2023 New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

"New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape" is Venture Planning Group's new seven-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U....

 

$9500.00
       
2023 World Hemostasis Testing Market Country Segment Forecasts Market Shares

This new reports from Venture Planning Group provides forecast for 40 major procedures by country and market segment, as well as sales and market shares for the reagent and instrument suppliers.

 

$9500.00
       
2023 Latin America Hemostasis Diagnostics Market: Reagent and Instrument Sales Forecasts, Volume Projections for 40 Tests, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers

This new 22-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$9500.00
       
2023 Analysis of the Global Nucleic Acid Testing Market:
Innovative Technologies and Emerging Business Opportunities


Rationale

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches....


 

$9500.00
       
Competing in the 2023 Global Nucleic Acid Testing/NAT Market

This new seven-country study from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

 

$9500.00
       
Analysis of the Enteric Disease Testing Market in Europe:
Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia


This new report from Venture Planning Group provides analysis of the European enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

About this Report

This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK)....


 

$9400.00
       
Respiratory Diseases: Global Market Outlook and Emerging Opportunities

This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis....

 

$9200.00
       
Global Hepatitis Diagnostics Market: Growth Opportunities and Business Expansion Strategies

This 320-page report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan.�Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed....


 

$8750.00
       
2023 Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

This new seven-country study from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.


 

$8750.00
       
Competitive Analyses of Major and Emerging Suppliers
Of Immunodiagnositcs, Microbiology, Cancer Diagnostic,
Molecular Diagnostic, Hematology, Coagulation
And Blood Banking Instruments and Reagents


This report presents strategic profiles of major and emerging suppliers of diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$8500.00
       
Competitive Intelligence: Analyses of Current and Emerging Suppliers
Of Immunodiagnositcs, Microbiology, Cancer Diagnostic,
Molecular Diagnostic, Hematology, Coagulation
And Blood Banking Instruments and Reagents


This new report from Venture Planning Group provides analyses of Currrent and emerging suppliers of immunodiagnositcs, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents. The report presents strategic profiles of current and emerging suppliers of diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$8500.00
       
Current and Emerging Suppliers
Of Immunodiagnostic, Microbiology, Cancer Diagnostic,
Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents


This new report from Venture Planning Group provides analyses of current and emerging suppliers of immunodiagnostics, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents. The report presents strategic profiles of 100 major and emerging suppliers of diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.



 

$8500.00
       
Abbott: Diagnostics Sales, Market Shares and Competitive Position by Product and Country

This unique market intelligence report from Venture Planning Group provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Abbott and its main competitors, as well as a profile of the company�s diagnostics business.



 

$8500.00
       
2015 Emerging Blood Banking, Cancer Diagnostic, Coagulation, Hematology, Immunodiagnostic, Microbiology, and Molecular Diagnostic Instrument and Reagent Competitors

This new report from VPGMarketResearch.com provides analyses of current and emerging suppliers of immunodiagnostics, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents....

 

$8500.00
       
2016 Analyses of Current and Emerging Suppliers of Immunodiagnostics, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents

This new report from VPGMarketResearch.com provides analyses of 100 major and emerging suppliers of immunodiagnostics, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents....

 

$8500.00
       
Competitive Analysis of Leading Suppliers of Blood Banking, Cancer Diagnostic, Coagulation, Hematology, Immunodiagnostic, Microbiology, and Molecular Diagnostic Instrument and Reagents

This new report from VPGMarketResearch.com provides analyses of current and emerging suppliers of immunodiagnostics, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood banking instruments and reagents....

 

$8500.00
       
2023 Asia-Pacific Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

This new 18-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$8500.00
       
2023 Asia-Pacific Coagulation Testing Market: Reagent and Instrument Sales Forecasts, Volume Projections for 40 Tests, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers

This new 18-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$8500.00
       
« Previous     1  2  3  4  5  6  7  8  9  10   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X